(C) World Health Organization
This story was originally published by World Health Organization and is unaltered.
. . . . . . . . . .



WHO at the 25th International Union Against STIs World Congress [1]

[]

Date: 2024-09-17

WHO is participating at the 25th IUSTI World Congress (IUSTI) taking place in Sydney, Australia, from 17–20 September 2024. With a pre-conference session and WHO-led satellite events, the Organization will share its latest epidemiological, scientific and normative work related to sexually transmitted infections (STIs).

Agenda

Mobilize for action on sexually transmitted infections

Tuesday, 17 September 2024, 11:00–12:30



In partnership with IAS and IUSTI, a pre-conference on STIs will include a diverse group of stakeholders –including civil society, community leaders, public health and clinical experts, programme managers, and policymakers – to catalyze action targeting the elimination of STIs as a public health concern by 2030.

Building on the momentum from the first forum in Berlin, Germany, following the World Health Summit 2023, and from the AIDS 2024 pre-conference in Munich, Germany, this meeting will outline concrete next steps to increase political commitment, community engagement and innovation in global health.

Chairpersons: Ismail Maatouk (WHO) and Remco Peters (WHO) Why do STIs matter? WHO perspective – Ismail Maatouk (WHO)

IUSTI perspective – Janet Wilson (IUSTI)

IAS perspective – Andrew Grulich (IAS) Critical accelerator 1: accelerating innovation Background and context – Remco Peters (WHO)

Diagnostics (Rapid POCT) in STIs – Rebecca Guy (Kirby institute)

STIs vaccines – Kate Seib (Griffith University) Critical accelerator 2: increasing political commitment Background and context – Nicola Low (University of Bern)

Perspective from Fiji – Rachel Devi (Ministry of Health, Fiji)

Perspective from PNG – Petronia Kaima (Public Health Division, PNG) Critical accelerator 3: Strengthening community mobilization Background and context – Midnight Poonkasetwattana (APCOM)

Perspective from Indigenous populations – Simon Graham (University of Sydney)

Perspective from Key populations – Rena Janamnuaysook (Institute of HIV Research and Innovation (IHRI), Thailand) Closing remarks Ismail Maatouk (WHO), Remco Peters (WHO) Hide agenda Show agenda

Strategies to outsmart antimicrobial resistance in gonorrhoea

Thursday, 19 September 2024, 11:00–12:30

A session will overview strategies to outsmart antimicrobial resistance (AMR) in gonorrhoea including epidemiological updates based on the Enhanced Gonorrhoea AMR Surveillance Programme (EGASP) data and from regions and countries.

AMR stewardship will be discussed as well as strategies for implementing new therapeutics and novel methods for AMR surveillance in the era of DoxyPEP and other emerging STI prevention tools.

Chairpersons: Jo-Anne Dillon (IUSTI), Ismail Maatouk (WHO), Remco Peters (WHO) Neisseria gonorrhoeae AMR: global perspective – Ismail Maatouk (WHO)

Country updates on emerging gonorrhoea AMR: data from Australia and China – Monica Lahra (The Prince of Wales Clinical School, UNSW, Sydney) and Xiao-Hong Su (Hospital for Skin Diseases Institute of Dermatology, CAMS & PUMC, China) AMR stewardship Advanced diagnostic tools for AMR gonorrhoea – Barbara van der Pol (University of Alabama at Birmingham, USA)

Evidence for different treatment recommendations in different settings – David Lewis (university of Sydney) Strategies for implementing new therapeutics – Moderator: Jo-Anne Dillon (IUSTI) Strategies on introducing novel antibiotics – Remco Peters (WHO)

Access and conserving new therapeutics – Fernando Martinez (GARDP) and Caroline Perry (GSK)

What is needed in the laboratory? – Magnus Unemo (Örebro University, Sweden) Monitoring emerging challenges in AMR gonorrhoea Novel methods for AMR surveillance in the era of DoxyPEP and other emerging STI prevention tools – Yonatan Grad (Harvard T.H. Chan School of Public Health, USA Closing remarks – Ismail Maatouk (WHO), Remco Peters (WHO) Hide agenda Show agenda

Key global challenges and solutions in addressing (re)emerging STIs

Friday, 20 September 2024, 13:30–15:00

Syphilis will be highlighted including the elimination of the mother-to-child transmission of syphilis in the Pacific Region, implementation of syphilis rapid diagnostic tests in healthcare programmes and treatment of syphilis in pregnancy.

Furthermore, considering the recent growing mpox outbreaks in several countries including new ones, and the new mpox strain behind recent cases, continued spread of mpox globally and in the Regions of the Western Pacific and South-East Asia will be highlighted from a sexual health perspective.

[END]
---
[1] Url: https://www.who.int/news-room/events/detail/2024/09/17/default-calendar/who-at-the-25th-international-union-against-stis-world-congress

Published and (C) by World Health Organization
Content appears here under this condition or license: Creative Commons CC-BY-NC-SA 3.0 IGO.

via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/who/

You are viewing proxied material from magical.fish. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.